Drug Approval Priorities
May 27, 2005
May 27, 2005 -- Last week, the American Sheep Industry Association (ASI) was invited to meet with the National Research Support Project No. 7 (NRSP-7) committee to discuss drug-approval priorities for the sheep industry. The shortage of drugs for minor food animal uses is a problem well recognized by sheep producers, veterinarians, animal scientists and regulators.
NRSP-7 is a cooperative project funded by the U.S. Department of Agriculture?s (USDA) Cooperative State Research, Education and Extension Service (CSREES). It is designed to address the shortage of minor use animal drugs by funding and overseeing the efficacy, animal safety, human food safety research, and environmental assessment required for drug approval.
The NRSP-7 committee of scientists from around the United States works collaboratively with the Food and Drug Administration?s Center for Veterinary Medicine, USDA/CSREES, other government agencies, universities, State Agricultural Experiment Stations and veterinary schools to get the job done.
Cindy Wolf, DVM, (Minn.) presented to NRSP-7, on behalf of ASI, the industries most prominent drug needs which range from new de-worming products to mastitis treatments.
?This was a great opportunity for the industry to present our priorities to NRSP-7 and to interact with the members of the committee. We were able to give them a snap-shot of the diversity and unique nature of the U.S. sheep industry,? commented Paul Rodgers, deputy director of policy for ASI.
Staff contact: Paul Rodgers, 303-771-3500